ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1453

Estrogen Receptor Alpha Impacts Th17 Expansion in Murine Lupus

Melissa A. Cunningham1, Osama S. Naga2, Jackie G. Eudaly3 and Gary S. Gilkeson4, 1Med/Rheumatology, MUSC, Charleston, SC, 2Medicine/Rheumatology, Medical University of South Carolina, Charleston, SC, 3Med/Rheumatology, Medical University of SC, Charleston, SC, 4Department of Medicine, Division of Rheumatology, Medical University of South Carolina, Charleston, SC

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: hormones and systemic lupus erythematosus, T cells

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Systemic Lupus Erythematosus - Animal Models

Session Type: Abstract Submissions (ACR)

Background/Purpose: Systemic lupus erythematosus is a disease that disproportionately affects females. The mechanisms underlying the female predominance in this disease are largely unknown. We previously showed that estrogen receptor alpha (ERα) deficiency resulted in significantly reduced renal disease and increased survival in murine lupus. More recently we showed a role for ERα in TLR induction of the IL-23/IL-17 inflammatory pathway. TLR7 and TLR9 agonists induced significant increases in IL-1β and IL-23 expression in dendritic cells derived from ERα+/+, but not ERα-/- mice. Additionally, TLR7 and TLR9 stimulation upregulated IL-23R, which is critical for the stabilization of the Th17 cell phenotype, but this effect could not be demonstrated in the absence of ERα. We hypothesized that the capacity to expand/stabilize Th17 cells is partially regulated by ERα. 

Methods: NZM2410 lupus-prone mice (n=19) were sacrificed at 17-19wks and spleens were harvested. T cells were isolated and analyzed prior to and after 4-5d Th17 polarizing conditions (stimulated with CD3/CD28 beads, +TGFβ, +IL-6, +anti-IFNγ, +anti-IL-4; +IL-23 on d3). Flow cytometry, ELISA and RT-PCR were used to evaluate IL-17/CD4 positivity, and IL-21, ICOS, IL-23R message levels, respectively. 

Results: Consistent with previous experiments that demonstrated reduced IL-17-producing ex vivo spleen cells from ERα deficient mice, we now show that T cells isolated from NZM2410 ERα-/- mice also produce less IL-17 and have reduced IL-21, ICOS, and IL23R mRNA levels compared with WT NZM2410.  In addition, under Th17 polarizing conditions, fewer Th17 (IL17+/CD4+) cells were attained from NZM2410 ERα-/- mice. 

Conclusion: T cells from lupus-prone ERα-/- mice express less IL-17 and other markers of Th17 development and stabilization. Taken together, our previous and current data suggest that ERα impacts the IL-23/IL-17 inflammatory pathway. A reduction in Th17 cells may partially explain the decrease in inflammatory renal damage and increased survival in ERα deficient animals.


Disclosure:

M. A. Cunningham,
None;

O. S. Naga,
None;

J. G. Eudaly,
None;

G. S. Gilkeson,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/estrogen-receptor-alpha-impacts-th17-expansion-in-murine-lupus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology